SuperNova Diagnostics(R) Announces Agreement with KSB Diagnostics of China

WASHINGTON, LONDON and HONG KONG, March 17, 2011 - SuperNova Diagnostics(R), Inc., a privately-held global diagnostics
company for human and non-human health applications, announced today that it
has signed an agreement with Shenzhen Kang Sheng Bao Bio-Technology Co., Ltd.
("KSB"), a biotechnology diagnostics company specializing in research,
manufacture and distribution of in-vitro diagnostic kits and research
reagents in China and affiliated markets. Financial terms of the agreement
were not disclosed.

"We are delighted to announce this agreement with KSB Diagnostics, a
leader in China and Asia for diagnostics," said Neil Campbell, president &
CEO of SuperNova Diagnostics. "This collaborative relationship allows
SuperNova and KSB to expand R&D, manufacturing and commercialisation into one
of the world's largest markets."

About AmpCrystal(R) Technology

AmpCrystal(R), SuperNova Diagnostics' lead technology with multiple
product formats, allows for minimally trained individuals (advanced
CLIA-waived) to test for a wide range of protein analytes and can detect
directly un-amplified DNA in humans, animals or environmental samples.
AmpCrystal(R) is hyper-dense, energy-mediated proprietary nanocrystals that
can be utilised in a wide variety of diagnostic applications and
configurations. The technology platform lends itself to both
forward-integration into new product formats as well as backward compatible
into existing open and closed diagnostic systems.

Time-to-result has been shown in prototypes to be reduced to minutes on
the spot versus the hours or days required when sending samples to a central
laboratory or processing in regional satellite laboratories. With three
integrated capabilities (sample collector/processor, analytical disposable,
and the readout device), the technology is simpler, more robust, faster and
significantly less expensive than existing POC systems.

About Shenzhen Kang Sheng Bao Bio-Technology Co. Ltd "KSB"

KSB provides innovative diagnostic kits and technologies to serve the
large developing market in China and is a leader in vitro diagnostic
reagents, OEM manufacture and contractual R&D and through partnerships
possesses products with international brand (such as drugs, medical devices,
bio-products, diagnostic kits, scientific research instruments, etc.), and
has business relations with more than 30 countries and regions.

For additional information, please visit
www.ksbbiotech.com/en/index.html

About SuperNova Diagnostics(R), Inc.

SuperNova(R) is a development-stage diagnostics company with a
proprietary platform for conducting diagnostics at the site of interest with
point-of-care in human health and point-of-use for non-human health
applications. A powerful proprietary nanochemistry, AmpCrystal(R), can
deliver novel, next generation performance for pathogens, proteins, and
directly measure DNA without PCR with ultra-low sensitivity and specificity
while not sacrificing a dynamic range of measurements. SuperNova can be
utilized in a wide range of diagnostic formats (lateral flow, self-contained
cartridges, microtitre, microarrays, closed systems, research products and
OEM). SuperNova(R) - Putting the Laboratory in the Palm of Your Hand(R).

For additional information, please visit
www.supernovadiagnostics.com.

    Media Contacts:
    Tiberend Strategic Advisors, Inc.
    +1-212-827-0020
    Farrell Denby, fdenby@tiberend.com
    or
    Tamara Bright, tbright@tiberend.com

Farrell Denby, fdenby at tiberend.com, or Tamara Bright, tbright at tiberend.com, both of Tiberend Strategic Advisors, Inc., +1-212-827-0020